Lazard Asset Management’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.5M | Buy |
1,450,421
+44,128
| +3% | +$106K | ﹤0.01% | 839 |
|
|
2025
Q1 | $3.11M | Sell |
1,406,293
-41,421
| -3% | -$91.5K | ﹤0.01% | 829 |
|
|
2024
Q4 | $7.89M | Buy |
1,447,714
+127,672
| +10% | +$696K | 0.01% | 526 |
|
|
2024
Q3 | $11M | Buy |
1,320,042
+169,468
| +15% | +$1.41M | 0.01% | 447 |
|
|
2024
Q2 | $8.24M | Buy |
1,150,574
+785,415
| +215% | +$5.62M | 0.01% | 553 |
|
|
2024
Q1 | $3.17M | Buy |
365,159
+359,411
| +6,253% | +$3.12M | ﹤0.01% | 761 |
|
|
2023
Q4 | $37K | Buy |
5,748
+1,934
| +51% | +$12.4K | ﹤0.01% | 1971 |
|
|
2023
Q3 | $37K | Buy |
3,814
+159
| +4% | +$1.54K | ﹤0.01% | 1942 |
|
|
2023
Q2 | $44K | Sell |
3,655
-5,695
| -61% | -$68.6K | ﹤0.01% | 1874 |
|
|
2023
Q1 | $130K | Buy |
9,350
+6,027
| +181% | +$83.8K | ﹤0.01% | 1433 |
|
|
2022
Q4 | $47K | Buy |
3,323
+3,283
| +8,208% | +$46.4K | ﹤0.01% | 1849 |
|
|
2022
Q3 | $1K | Sell |
40
-61
| -60% | -$1.53K | ﹤0.01% | 2259 |
|
|
2022
Q2 | $2K | Hold |
101
| – | – | ﹤0.01% | 2295 |
|
|
2022
Q1 | $3K | Sell |
101
-211
| -68% | -$6.27K | ﹤0.01% | 2220 |
|
|
2021
Q4 | $13K | Sell |
312
-351,638
| -100% | -$14.7M | ﹤0.01% | 2103 |
|
|
2021
Q3 | $17.3M | Sell |
351,950
-1,366,771
| -80% | -$67.1M | 0.02% | 517 |
|
|
2021
Q2 | $71.7M | Sell |
1,718,721
-1,642,546
| -49% | -$68.5M | 0.08% | 215 |
|
|
2021
Q1 | $120M | Sell |
3,361,267
-54,030
| -2% | -$1.93M | 0.15% | 127 |
|
|
2020
Q4 | $95.8M | Buy |
+3,415,297
| New | +$95.8M | 0.12% | 153 |
|